[12] People with Crohn's disease, especially those with ileal involvement, may already have a higher baseline risk of gallstone formation [21] [22] Dehydration and acute kidney injury : Persistent vomiting or diarrhoea can lead to dehydration, particularly in vulnerable patients Bowel obstruction : For individuals with Crohn's disease, especially those with known strictures, the risk of obstruction may theoretically be increased due to the medication's effect on gastrointestinal motility Practical strategies to minimise side effects include: Starting with a low dose and gradually increasing as tolerated Eating smaller, lower-fat meals and avoiding overeating Maintaining adequate hydration Temporarily pausing dose escalation if symptoms become intolerable Patients should be advised to contact their GP or specialist immediately if they experience: Severe, persistent abdominal pain (especially if radiating to the back) Persistent vomiting preventing adequate fluid intake Signs of dehydration Blood in stools or black, tarry stools Symptoms suggesting bowel obstruction (severe cramping, inability to pass stool or gas, abdominal distension) Suspected adverse reactions should be reported via the Yellow Card Scheme (yellowcard.mhra.gov.uk or the Yellow Card app)

Blood sugar lowering: If you are diabetic or on blood sugar-lowering medication, berberine may enhance their effect and require monitoring
This publication hasn't received compensated product samples for testing, hasn't interviewed brand personnel, hasn't been granted access to internal product specifications beyond what is publicly published, and hasn't conducted laboratory or field performance testing of GLPro GLPatch
there is no documented protocol for intermediate values like 3.75 mg or 11 mg, and there is nothing documented above 15 mg
Black communities are 20% more likely to get colorectal cancer and 40% more likely to die from it